Ubiquitination signature identified in neuroendocrine prostate cancer with therapeutic implications
A ubiquitination-centered signature linked to neuroendocrine prostate cancer (NEPC) was identified, highlighting its role in lineage plasticity.
Indication
Clinical and regulatory intelligence for Prostate Cancer with 10 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.